MedTrace Logo

Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19

NCT04624503 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-11-10

No results posted yet for this study

Summary

COVID-19 infection has been associated with numerous cardiac manifestations. Indeed, SARS-CoV-2 may impact on cardiovascular system through a direct myocardial infection or a secondary cardiac involvement due to hypoxia or metabolic supply-demand imbalance or prothrombotic inflammatory state. As a consequence of and besides acute myocardial damages, COVID-19 could also determine chronic cardiovascular consequences, with a significant impact on long-term prognosis, quality of life and functional capacity of COVID-19 survivors.

On this basis, we aim to define the clinical and prognostic effects of myocardial involvement in COVID-19 patients.

Conditions

Sponsors & Collaborators

  • Centro Cardiologico Monzino

    collaborator OTHER

  • IRCCS Policlinico S. Donato

    collaborator OTHER

  • Istituti Clinici Scientifici Maugeri SpA

    collaborator OTHER

  • Istituto Auxologico Italiano

    collaborator OTHER

  • Humanitas Hospital, Italy

    lead OTHER

Principal Investigators

  • Gianluigi Condorelli, Prof · Humanitas Research Hospital IRCCS, Rozzano-Milan

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-06-01
Completion
2021-10-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04624503 on ClinicalTrials.gov